After a succesfull partnership launch with Mammotome - Leica Biosystems in 2017, RMS now also proubly announces the exclusive partnership for the HydroMark portfolio in the Netherlands (previously distributed by Tromp Medical)

As of February 2018, RMS Medical Devices will be the exclusive direct distribution partner for all HydroMark products in the entire BENELUX and all orders can be transferred to sales@rmsmedicaldevices.com

HydroMARK’s exclusive hydrogel technology provides clinicians with unmatched long-term ultrasound visibility after marking a post-breast-biopsy-site or breast-lesion.

HydroMARK marker hydrates to provide 12-15 months of Ultrasound visibility. It is Ultrasound visible even after Neoadjuvant Chemotherapy.

For more info please feel free to contact your RMS Product Consultant or visit our HydroMark product website: http://www.mammotome.com/breast-biopsy-markers/hydromark/